• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1 kHz 纯音阈值在急性低频感音神经性听力损失中的意义。

Significance of 1 kHz Pure-tone Threshold in Acute Low-frequency Sensorineural Hearing Loss.

机构信息

Department of Otolaryngology-Head and Neck Surgery, Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan.

Department of Otorhinolaryngology, College of Medicine, Konyang University.

出版信息

Otol Neurotol. 2018 Dec;39(10):e950-e955. doi: 10.1097/MAO.0000000000002023.

DOI:10.1097/MAO.0000000000002023
PMID:30444841
Abstract

OBJECTIVES

To analyze risk factors for acute low-frequency hearing loss (ALFHL), and compare treatment outcomes in the presence or absence of such risk factors.

STUDY DESIGN

A case series featuring retrospective chart review.

SETTING

An academic university hospital.

PATIENTS

We included 170 ALFHL patients without vertigo. All of the patients received one of four treatments: low-dose steroid (LD-steroid), high-dose steroid (HD-steroid), LD-steroid and diuretics (LD-combination therapy), and ITDI (intratympanic dexamethasone injection) and diuretics (ITDI-combination therapy). To identify risk factors, we reviewed the clinical features of patients such as age, sex, chief complaint, accompanying symptoms, diabetes, hypertension, time from disease onset, the extent of hearing loss, treatment methods, and 1 kHz involvement.

INTERVENTIONS

ALFHL was diagnosed based on the average hearing loss >30 dB at 250 and 500 Hz.

RESULTS

The overall rates of hearing recovery were 70-80% in the four treatment groups. In terms of the prognosis of ALFHL patients, we found that a longer time from disease onset and 1 kHz involvement were independent risk factors for poor prognosis. In addition, we compared treatment outcomes of four treatment methods in the presence or absence of risk factors. In ALFHL patients with risk factors, we found statistically significant differences (p = 0.042) among treatment methods; effectiveness ranged in the order if ITDI-combination therapy, LD-combination therapy, HD-steroid, and LD-steroid.

CONCLUSIONS

Risk factors for poor hearing recovery in ALFHL included longer symptom duration and 1 kHz involvement. In ALFHL with such risk factors, combination therapy was more effective than oral steroid therapy.

摘要

目的

分析急性低频感音神经性听力损失(ALFHL)的危险因素,并比较存在或不存在这些危险因素时的治疗效果。

研究设计

回顾性病例系列研究。

设置

学术大学医院。

患者

我们纳入了 170 例无眩晕的 ALFHL 患者。所有患者均接受了以下四种治疗之一:低剂量类固醇(LD-steroid)、高剂量类固醇(HD-steroid)、LD-类固醇和利尿剂(LD-combination therapy)以及鼓室内地塞米松注射和利尿剂(ITDI- combination therapy)。为了确定危险因素,我们回顾了患者的临床特征,如年龄、性别、主要诉求、伴随症状、糖尿病、高血压、发病时间、听力损失程度、治疗方法以及 1kHz 受累情况。

干预措施

根据 250 和 500Hz 平均听力损失>30dB 诊断 ALFHL。

结果

四组治疗的听力恢复总体率为 70-80%。就 ALFHL 患者的预后而言,我们发现发病时间较长和 1kHz 受累是预后不良的独立危险因素。此外,我们比较了存在或不存在危险因素时四种治疗方法的治疗效果。在有危险因素的 ALFHL 患者中,我们发现治疗方法之间存在显著差异(p=0.042);有效性按 ITDI- combination therapy、LD- combination therapy、HD-steroid 和 LD-steroid 的顺序排列。

结论

ALFHL 听力恢复不良的危险因素包括症状持续时间较长和 1kHz 受累。在有这些危险因素的 ALFHL 中,联合治疗比口服类固醇治疗更有效。

相似文献

1
Significance of 1 kHz Pure-tone Threshold in Acute Low-frequency Sensorineural Hearing Loss.1 kHz 纯音阈值在急性低频感音神经性听力损失中的意义。
Otol Neurotol. 2018 Dec;39(10):e950-e955. doi: 10.1097/MAO.0000000000002023.
2
Potential Benefits of Combination Therapy as Primary Treatment for Sudden Sensorineural Hearing Loss.联合疗法作为突发性感音神经性听力损失主要治疗方法的潜在益处。
Otolaryngol Head Neck Surg. 2016 Feb;154(2):328-34. doi: 10.1177/0194599815615121. Epub 2015 Nov 10.
3
The efficiency of intratympanic dexamethasone injection as a sequential treatment after initial systemic steroid therapy for sudden sensorineural hearing loss.鼓室内地塞米松注射作为初始全身类固醇治疗突发性聋后的序贯治疗的效果。
Eur Arch Otorhinolaryngol. 2011 Jun;268(6):833-9. doi: 10.1007/s00405-010-1476-8. Epub 2011 Jan 8.
4
Comparison of intermittent intratympanic steroid injection and near-continual transtympanic steroid perfusion as salvage treatments for sudden sensorineural hearing loss.间歇性鼓室内类固醇注射与持续经鼓室类固醇灌注治疗突发性聋的疗效比较。
Laryngoscope. 2013 Sep;123(9):2264-9. doi: 10.1002/lary.23909. Epub 2013 Jun 26.
5
Intratympanic steroid injections as a salvage treatment for sudden sensorineural hearing loss: a randomized, double-blind, placebo-controlled study.鼓室内类固醇注射作为突发性聋的挽救性治疗:一项随机、双盲、安慰剂对照研究。
Otol Neurotol. 2011 Jul;32(5):774-9. doi: 10.1097/MAO.0b013e31821fbdd1.
6
Potential benefits of salvage intratympanic dexamethasone injection in profound idiopathic sudden sensorineural hearing loss.挽救性鼓室内注射地塞米松治疗特发性突发性重度感音神经性聋的潜在获益。
Eur Arch Otorhinolaryngol. 2020 Aug;277(8):2219-2227. doi: 10.1007/s00405-020-05967-z. Epub 2020 Apr 15.
7
Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.全身治疗失败后鼓室内注射地塞米松治疗突发性感音神经性听力损失
Laryngoscope. 2007 Jan;117(1):3-15. doi: 10.1097/01.mlg.0000245058.11866.15.
8
The Short- and Long-Term Outcome of Intratympanic Steroid Therapy as a Salvage Treatment for Acute Low-Tone Sensorineural Hearing Loss without Episodes of Vertigo.鼓室内注射类固醇疗法作为无眩晕发作的急性低频感音神经性听力损失挽救治疗的短期和长期疗效
Audiol Neurootol. 2016;21(3):132-40. doi: 10.1159/000444577. Epub 2016 Apr 15.
9
Intratympanic dexamethasone/hyaluronic acid mix as an adjunct to intravenous steroid and vasoactive treatment in patients with severe idiopathic sudden sensorineural hearing loss.鼓室内地塞米松/透明质酸混合剂作为静脉类固醇和血管活性药物治疗严重特发性突发性聋患者的辅助治疗。
Otol Neurotol. 2011 Jul;32(5):756-60. doi: 10.1097/MAO.0b013e31821a3fc3.
10
Intratympanic dexamethasone injection for refractory sudden sensorineural hearing loss.鼓室内注射地塞米松治疗难治性突发性感音神经性听力损失
Laryngoscope. 2006 May;116(5):747-52. doi: 10.1097/01.mlg.0000205183.29986.f6.

引用本文的文献

1
Prognosis of Acute Low-Tone Hearing Loss Without Vertigo: A Scoping Review.急性低频感音神经性聋伴眩晕的预后:系统评价。
Laryngoscope. 2023 Oct;133(10):2457-2469. doi: 10.1002/lary.30630. Epub 2023 Mar 7.
2
Combination Therapy and Single-Modality Treatment for Acute Low-Tone Hearing Loss: A Meta-Analysis with Trial Sequential Analysis.急性低频感音神经性听力损失的联合治疗与单模态治疗:一项采用试验序贯分析的Meta分析
Brain Sci. 2022 Jun 30;12(7):866. doi: 10.3390/brainsci12070866.
3
Optimal First-Line Therapy for Acute Low-Tone Sensorineural Hearing Loss.
急性低频感音神经性听力损失的最佳一线治疗方案
J Audiol Otol. 2021 Oct;25(4):209-216. doi: 10.7874/jao.2021.00269. Epub 2021 Jun 30.